… Rouleau, MD; Eugene Braunwald, MD, on behalf of the SAVE Investigators* Background
In the Survival and Ventricular Enlargement (SAVE) trial, recurrent myocardial infarction (MI) …

… has never been tested in a large post–myocardial infarction patient population. … myocardial
infarction, and subsequent adverse clinical events in the 2231 patients enrolled in the SAVE …

… for adverse events after acute myocardial infarction (MI). … Survival and Ventricular Enlargement
(SAVE) trial were studied… >2.5 mg/dl were excluded from SAVE. WRF was defined as an …

… Enlargement (SAVE) trial.4 In SAVE, survivors of a myocardial infarction with compromised
… administered previously to patients after myocardial infarction and/or with left ventricular …

Objectives : The aim of this study was to determine the prognostic value of right ventricular (RV)
function in patients after a myocardial infarction (MI). Background : Right ventricular …

… changes attributed to a myocardial infarction by a patient's physician or as a fatality attributed
to infarction identified by the SAVE mortality committee. The SAVE study collected data …

… of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left
ventricular dysfunction after myocardial infarction: … events after acute myocardial infarction: the …

… In 15 countries and 1081 hospitals, 41,021 patients with evolving myocardial infarction
were randomly assigned to four different thrombolytic strategies, consisting of the use of …

… We found that patients with myocardial infarction who were treated at hospitals that had
been part of the SAVE trial were not more likely to be prescribed an ACE inhibitor at the time of …

… Because the distribution of infarct size data is consistently nonnormal, the sample … infarct
size data from studies carefully matched to the conditions of our investigation (mean [SD] infarct …